Articles

Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
Vol. 105 No. 7 (2020): July, 2020 https://doi.org/10.3324/haematol.2019.230649